PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 69.60
+0.20 (0.29%)
Jan 22, 2026, 11:50 AM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 9.97 billion as of January 21, 2026. Its market cap has decreased by -23.74% in one year.
Market Cap
9.97B
Enterprise Value
5.38B
Revenue
2.51B
Ranking
n/a
PE Ratio
5.97
Stock Price
69.60
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 9.97B, an increase of 85.38%. That is a compound annual growth rate of 4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 9.97B | -1.42% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 14.59B |
| Ever Supreme Bio Technology | 13.75B |
| Tanvex BioPharma | 13.53B |
| Medigen Vaccine Biologics | 12.31B |
| TCM Biotech International | 10.92B |
| TaiGen Biopharmaceuticals Holdings | 10.07B |
| Gongwin Biopharm Holdings | 9.67B |
| Acepodia | 8.59B |